News

The grant, which will total $265,000 each year, for the next three years, will be used solely to support and conduct basic and clinical research relating to kidney

Under the terms of the agreement, Cardiovascular Systems will distribute Invatec’s FDA-cleared percutaneous transluminal angioplasty (PTA) balloon catheter product line. The agreement is believed to expand Invatec’s US

Theravance, a biopharmaceutical company, has announced that the FDA has accepted for filing the new drug application for telavancin, a novel, bactericidal, once-daily injectable investigational antibiotic, for the

Through this acquisition, Sunwin expects to convert Qufu Shengren’s pharmaceutical production facilities to the production of high grade stevia in approximately three months saving substantial construction time for

In this collaboration, BG Medicine (BGM) will measure levels of Galectin-3 in patients enrolled in the study. Galectin-3 is a biomarker for cardiac remodeling associated with advanced stages

The Moroccan Industrial and Commercial Property Office granted the company its first Moroccan patent, which contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral

The clinical development plan for MPC-3100 is designed to expedite the drug candidate through the clinical development path. The Phase I trial will assess the safety and pharmacokinetics

Pursuant to the agreement, Avalon will withdraw its nominees for election to the board of directors. The parties have also agreed to add another mutually acceptable independent director

The agreement provides Merck with exclusive global rights to the oral formulation of vernakalant (vernakalant (oral)) for the maintenance of normal heart rhythm in patients with atrial fibrillation,